| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 05/01/1997 | WO1997015573A1 Process for the preparation of a growth hormone secretagogue |
| 05/01/1997 | WO1997015553A1 Hyroxamic acid derivatives |
| 05/01/1997 | WO1997015190A1 Thrombin inhibitors |
| 05/01/1997 | CA2235511A1 Process for the preparation of a growth hormone secretagogue |
| 05/01/1997 | CA2235371A1 Polymorphic forms of a growth hormone secretagogue |
| 05/01/1997 | CA2233860A1 Thrombin inhibitors |
| 04/30/1997 | CN1148503A Application of noval peptidic compound in preparation of medicine |
| 04/30/1997 | CN1034733C Spiro piperidines and homologs which promote release of growth hormone |
| 04/29/1997 | US5625072 Retroviral protease inhibiting compounds |
| 04/29/1997 | US5625066 Optically active hydroquinine (amino-3 phenyl)-1 ethanesulfonate, preparation and use thereof |
| 04/29/1997 | US5624939 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders |
| 04/29/1997 | US5624936 Inhibitors of farnesyl-protein transferase |
| 04/29/1997 | US5624921 Hypotriglyceridemic aminoacetylmercapto derivatives |
| 04/29/1997 | US5624903 Phosphoinositol-glycan-peptide with insulin-like action |
| 04/29/1997 | US5624894 Brain-enhanced delivery of neuroactive peptides by sequential metabolism |
| 04/24/1997 | WO1997014443A1 Magnetically labeled chemoattractants as targeted contrast agents in the nmr imaging of living tissues |
| 04/24/1997 | WO1997014417A1 Fibrinogen receptor antagonists |
| 04/24/1997 | WO1997008934A3 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 04/24/1997 | CA2234967A1 Fibrinogen receptor antagonists |
| 04/23/1997 | EP0769498A1 Sulfonamide derivatives with elastase inhibiting activity |
| 04/23/1997 | EP0769006A1 Small molecule inhibitors of rotamase enzyme activity |
| 04/23/1997 | EP0768898A1 Cascade-polymer complexes and methods of producing the same |
| 04/23/1997 | EP0768888A1 Use of muramyl peptide compounds |
| 04/23/1997 | EP0626942B1 Bicyclo[2.2.2.]octane derivatives as cholestocystokinin inhibitors |
| 04/23/1997 | CN1148392A Peptide derivative |
| 04/23/1997 | CN1148391A Increased bioavailability of biologically active compounds by linking to polypyrrolecarboxamido-naphthalene derivatives |
| 04/22/1997 | US5623079 Reacting aspartic acid with acetic anhydride and formic acid to form n-formyl-l-aspartic anhydride, centrifuging to form a cake, back-pressurizing, depressurizing, filtering or dehydrating |
| 04/22/1997 | US5623052 Oligopeptide |
| 04/22/1997 | US5623049 Flexible antisense agents comprising oligonuceotides having the (deoxy)ribose backbone replaced by an oligopeptide; protease- and nuclease-resistant; viricides; attached to carriers able to penetratate in cells |
| 04/22/1997 | US5622983 N-substituted cycloalkyl and polycycloalkyl α-substituted Trp-Phe- and phenethylamine derivatives |
| 04/22/1997 | US5622973 Bone disorders |
| 04/22/1997 | US5622949 Aids therapy |
| 04/22/1997 | US5622934 Treating diabetes mellitus |
| 04/22/1997 | US5622830 Method of identifying interleukin 1β converting enzyme inhibitors |
| 04/22/1997 | CA2031265C Methods of detecting collagen degradation in vivo |
| 04/17/1997 | WO1997014038A1 Methods to identify modulators of cell signaling |
| 04/17/1997 | WO1997013778A1 A metastasis suppressor gene |
| 04/17/1997 | CA2233313A1 Methods to identify modulators of cell signaling |
| 04/16/1997 | EP0768384A1 Improved enzymatic coupling reaction of N-protected-L-aspartic acid and phenylalanine methyl ester |
| 04/16/1997 | EP0768317A1 UCK14 compounds |
| 04/16/1997 | EP0768308A1 New derivatives of pyroglutaminic acid, preparation process and applications |
| 04/16/1997 | EP0768041A1 Sweetener salts |
| 04/16/1997 | EP0767801A1 Endothelin antagonists ii |
| 04/16/1997 | EP0767800A1 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase |
| 04/16/1997 | EP0767674A1 Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin |
| 04/16/1997 | EP0767661A1 Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors |
| 04/16/1997 | CN1147819A New opioid peptide analogs with mixed MU agonist/delta antagonist properties |
| 04/16/1997 | CN1147818A New compound useful as a sweetener and its preparing process |
| 04/16/1997 | CN1147817A Improved method for the preparation of an aspartame-derived compound useful as a sweetener |
| 04/16/1997 | CN1147506A Benzoazepine-Benzooxaazepine-Benzothiaazepine-N-acetate derivant |
| 04/15/1997 | US5621137 Dissolving ester in water, charging to crystallizer containing circulating refrigeration medium, isolating pseudo solid phase |
| 04/15/1997 | US5620995 Substituted heterocyclic carboxyamides, their preparation and their use as pharmaceuticals |
| 04/15/1997 | US5620987 Amino acid derivatives |
| 04/15/1997 | US5620977 Retroviral protease inhibitors |
| 04/15/1997 | US5620953 Antiprotozoal cyclic tetrapeptides |
| 04/15/1997 | US5620675 Medical diagnosis |
| 04/10/1997 | WO1997012907A1 Peptide inhibitor for viral protease derived from the transframe region of the gag-pol gene |
| 04/10/1997 | WO1997012904A1 Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors |
| 04/10/1997 | WO1997012903A1 Compounds, compositions and methods for inhibiting the binding of proteins containing an sh2 domain to cognate phosphorylated proteins |
| 04/10/1997 | WO1997012902A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 04/10/1997 | WO1997012894A1 Preparation of glucosaminyl muramic acid derivatives |
| 04/10/1997 | WO1997012850A2 Bifunctional, sulphide-containing sulphonamide-chelating agents of xsny type for radioactive isotopes |
| 04/10/1997 | WO1997012625A1 Pharmaceutical angiostatic dipeptide compositions and methods of use thereof |
| 04/10/1997 | WO1997012624A1 Novel peptides |
| 04/10/1997 | CA2233272A1 Novel peptides |
| 04/10/1997 | CA2232620A1 Bifunctional sulfide-containing sulfonamide-chelating agents such as xsny for radioactive isotopes |
| 04/10/1997 | CA2231505A1 Preparation of glucosaminyl muramic acid derivatives |
| 04/10/1997 | CA2229434A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 04/09/1997 | EP0766696A1 Thiazolidine derivatives, their preparation and drugs containing same |
| 04/09/1997 | EP0766695A1 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders |
| 04/09/1997 | EP0766694A1 Peptide derivatives with metallopeptidase inhibitory activity |
| 04/09/1997 | EP0766683A1 Novel substituted purinyl derivatives with immunomodulating activity |
| 04/09/1997 | EP0345359B1 Novel hydroxamic acid derivative |
| 04/09/1997 | CN1147261A Factor Xa inhibitors |
| 04/09/1997 | CN1147260A Neurokinine (tachykinine) antagonists |
| 04/09/1997 | CN1147205A Antithrombotic agents |
| 04/09/1997 | CN1034505C Process for preparation of alpha-L-aspartyl-L-phenylalanine methyl ester hydrochloride |
| 04/08/1997 | US5618914 Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same |
| 04/08/1997 | US5618811 Gastrointestinal and central nervous system disorders |
| 04/08/1997 | US5618808 Benzothiazepine and benzoxazepine derivatives as cholecystokinin receptor antagonists |
| 04/08/1997 | US5618792 Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase |
| 04/08/1997 | US5618724 Antibiotics GE 37468 A, B and C |
| 04/08/1997 | US5618710 Resistance to exogenous proteolysis |
| 04/08/1997 | US5618528 Biologically compatible linear block copolymers of polyalkylene oxide and peptide units |
| 04/03/1997 | WO1997011964A1 Truncated glial cell line-derived neurotrophic factor |
| 04/03/1997 | WO1997011961A1 Peptide derivatives having endothelin receptor antagonistic activity |
| 04/03/1997 | WO1997011960A1 Antagonists of endothelin receptors |
| 04/03/1997 | WO1997011959A1 Biologically active mhc peptides having a repeated amino acid sequence motif |
| 04/03/1997 | WO1997011697A1 3-spirolactam, 3-spiroamino, 3-spirolactone and 3-spirobenzopyran piperidines and pyrrolidines promote release of growth hormone |
| 04/03/1997 | DE19536263A1 New hydroxy-substd. quinoline carboxamide derivs. |
| 04/03/1997 | CA2229263A1 Peptide derivatives, their production and use |
| 04/02/1997 | EP0765871A1 Substituted Quinoline-2-carboxamides, their preparation and their use as prolyle-4-hydroxylase Inhibitors |
| 04/02/1997 | EP0765864A1 Process for the separation of amino acids and aminosulfonic acids by adsorption to zeolites |
| 04/02/1997 | EP0765478A1 Positive and positive/negative cell selection mediated by peptide release |
| 04/02/1997 | EP0765340A1 Methionine sulfone and s-substituted cysteine sulfone derivatives as enzyme inhibitors |
| 04/02/1997 | EP0765339A1 3-amino-2-oxo-1-piperidineacetic derivatives containing an arginine mimic as enzyme inhibitors |
| 04/02/1997 | EP0765338A1 Arginine mimic derivatives as enzyme inhibitors |
| 04/02/1997 | CN1146770A Cephalosporin synthesis |
| 04/02/1997 | CN1146726A Block copolymers |
| 04/01/1997 | US5616791 Method of preparing L-aspartyl-D-α-aminoalkane carboxylic acid-(S)-N-α-alkylbenzylamide |